Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CVR

2 Fertilizer Stocks to Buy Now to Bet on a Continued Strait of Hormuz Closure

Disruptions in Strait of Hormuz shipping are impacting fertilizer prices, benefiting companies like CVR Partners and Intrepid Potash.

Barchart

As Energy Surges on Crack Spreads, Consider Taking Gains on 2 Small Cap Oil Stocks

Understand how crack spreads, not crude alone, is driving refiners during the Iran war, and what could pressure CVR Energy and PBF Energy stocks next.

MarketBeat

Covid-19 immunity could lower risk of another pandemic, study claims

Covid-19 has generated ‘a biological barrier to other coronaviruses’

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid-19 immunity likely to lower risk of another SARS pandemic – study

Researchers also found existing Covid-19 vaccines could help slow or stop the spread of a new coronavirus.

Evening Standard

2 Fertilizer Stocks to Buy as Prices Surge Amid Iran War

Iran's war is squeezing global fertilizer supply. Shares of CVR Partners and Intrepid Potash are surging, and prices could climb much higher this spring.

Barchart

3 Ultra-High Dividend Yield Picks for the New Year

Big dividend yields can mean a great payout for the value, and these three stocks provide some of the highest yields across the market.

MarketBeat

Half a million medical patients just had their addresses, dates of birth, SSNs and more stolen by hackers — how to stay safe

The Center for Vein Restoration has revealed that it fell victim to a data breach back in October and that hackers may have accessed medical files containing patient information.

Tom’s Guide

Read news from The Economist, FT, and more,
with one subscription

Stock Market Today: S&P 500 Nears 6K in Best Week of the Year

Optimism around Donald Trump's election win, the Fed rate cut and consumer sentiment sent markets to new highs Friday.

Kiplinger

Bone Health Focused Radius Health Goes Private In $890M Deal

Radius Health Inc (NASDAQ:RDUS) will be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million, including the assumption of debt and assuming full payment of the CVR (Contingent Value Right). Gurnet Point and Patient Square will pay $10.00 per share in cash plus a…

Benzinga

People

Donald Trump

206,349 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.